Merrimack Pharmaceuticals Inc

NASDAQ:MACK  
5.34
+0.08 (+1.62%)
Earnings Announcements

Merrimack Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:44 GMT
Merrimack Pharmaceuticals Inc (MACK) - Merrimack Reports First Quarter 2022 Financial Results.
Reported a Net Loss of $132 Thousand for Q1 Ended March 31, 2022, Or $0.01 per Basic and Diluted Share.